In the BioHarmony Drug Report Database

"Preview" Icon

Telavancin

Vibativ (telavancin) is a small molecule pharmaceutical. Telavancin was first approved as Vibativ on 2009-09-11. It is used to treat bacterial infections, infectious skin diseases, pneumonia, staphylococcal infections, and streptococcal infections in the USA. Vibativ’s patents are valid until 2027-01-01 (FDA).

 

Trade Name

 

Vibativ
 

Common Name

 

telavancin
 

ChEMBL ID

 

CHEMBL507870
 

Indication

 

bacterial infections, infectious skin diseases, pneumonia, staphylococcal infections, streptococcal infections
 

Drug Class

 

Vancomycin-related compounds

Image (chem structure or protein)

Telavancin structure rendering